IYK241220C75000
- 0.00
- 0.000.00%
Ishares U.S. Consumer Goods Etf Newsroom
What to Expect From Procter & Gamble in 2025
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Last Trading Day of 2024
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio For Q4
2024's Wildest Brand Marriages: From Tesla's Mezcal To Life-Size Polly Pocket
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
CVS Health Unusual Options Activity For December 30
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Tech-Driven Gains Falter at Year-End
DA Davidson Maintains Buy on Procter & Gamble, Maintains $209 Price Target
How Warren Buffett Decides When To Sell a Stock: 'If the Competitive Advantage Disappears...We Sell'
Weekly Buzz: So far, Santa is Letting us Down
Altria Group Options Trading: A Deep Dive Into Market Sentiment
Check Out What Whales Are Doing With Procter & Gamble
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Markets Sluggishly Move to Year-End
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
FDA Proposes Testing Talc Products for Asbestos: Report
Market Whales and Their Recent Bets on CVS Options
Real cocoa is unaffordable, the Confectioners company laboratory is looking for "alternatives."
Analysts say that if the method of obtaining cocoa does not change, there will be no chocolate in twenty years. With cell-cultivated cocoa, this Industry will no longer need to rely on nature. Chocolate and Confectioners companies are beginning to invest in companies that develop "lab cocoa." Earlier this month, the maker of Oreo participated in a seed round financing of 4.5 million dollars for the startup Celleste Bio, which focuses on cell-cultivated cocoa.
BofA Reports $10B in U.S. Equity Inflows, Marking Largest Weekly Surge Since 2017